You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p38 MAP kinase inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Worldwide (neflamapimod, )

Completed
Has Results
  • Alzheimer Disease
  • Long Beach, California
  • +37 more
Sep 28, 2021

Influenza, Human Trial in Leiden (POLB 001, Placebo)

Completed
  • Influenza, Human
  • POLB 001
  • Placebo
  • Leiden, Netherlands
    Centre for Human Drug Research
Mar 13, 2023

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Dementia With Lewy Bodies Trial in Lake Worth (Neflamapimod, Placebo)

    Recruiting
    • Dementia With Lewy Bodies
    • Lake Worth, Florida
      JEM Research Institute
    May 17, 2023

    Alzheimer's Disease, Mild Cognitive Impairment Trial in Amsterdam (VX-745)

    Completed
    Has Results
    • Alzheimer's Disease
    • Mild Cognitive Impairment
    • Amsterdam, Netherlands
      Alzheimer Research Center, VU Medical Center
    Mar 13, 2019

    Dementia With Lewy Bodies (DLB) Trial in Netherlands, United States (Neflamapimod)

    Completed
    Has Results
    • Dementia With Lewy Bodies (DLB)
    • La Jolla, California
    • +23 more
    Oct 28, 2021

    Advanced Cancer Trial in Rochester, San Antonio (LY2228820, Midazolam, Tamoxifen)

    Completed
    Has Results
    • Advanced Cancer
    • Rochester, Minnesota
    • +1 more
    Mar 8, 2020

    Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Aug 16, 2022

    BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Tumor Trial in Houston (biological, drug, other)

    Active, not recruiting
    • BRAF NP_004324.2:p.V600X
    • +6 more
    • Cetuximab
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Des Moines, Iowa
    • +8 more
    Jan 12, 2023

    EGFR NP_005219.2:p.S492R, KRAS Gene Mutation, MAP2K1 Gene Mutation Trial in Houston (other, biological, drug)

    Recruiting
    • EGFR NP_005219.2:p.S492R
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    LMNA-Related Dilated Cardiomyopathy Trial in United States (ARRY-371797, p38 inhibitor, oral)

    Completed
    Has Results
    • LMNA-Related Dilated Cardiomyopathy
    • ARRY-371797, p38 inhibitor, oral
    • Aurora, Colorado
    • +3 more
    Mar 3, 2022

    Dental Pain Trial in Austin, Salt Lake City (Placebo; oral, ARRY-371797, p38 inhibitor; oral, Celecoxib, COX-2 inhibitor; oral)

    Completed
    • Dental Pain
    • Placebo; oral
    • +2 more
    • Austin, Texas
    • +1 more
    Feb 7, 2021

    COVID-19 Trial in Worldwide (Losmapimod oral tablet, Placebo oral tablet)

    Terminated
    • COVID-19
    • Losmapimod oral tablet
    • Placebo oral tablet
    • Irvine, California
    • +15 more
    Mar 30, 2022

    Dental Pain Trial in San Marcos, Salt Lake City (ARRY-371797, p38 inhibitor; oral, Placebo; oral)

    Completed
    • Dental Pain
    • ARRY-371797, p38 inhibitor; oral
    • Placebo; oral
    • San Marcos, Texas
    • +1 more
    Feb 17, 2021

    Multiple Myeloma Trial in Rochester (procedure, biological, drug)

    Not yet recruiting
    • Multiple Myeloma
    • Biospecimen Collection
    • +12 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Sep 15, 2023

    CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

    Recruiting
    • CDKN2A-p16 Positive
    • +5 more
    • Tucson, Arizona
      The University of Arizona Medical Center-University Campus
    Mar 7, 2022

    Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

    Recruiting
    • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
    • +4 more
    • Chicago, Illinois
      Northwestern University
    Apr 30, 2021

    Arthritis, Rheumatoid Trial in Worldwide (, PH-797804)

    Completed
    Has Results
    • Arthritis, Rheumatoid
    • Malvern East, Victoria, Australia
    • +47 more
    Jul 26, 2021

    Real-life Current Standards of Care in Relapsed and/or

    Completed
    • Multiple Myeloma
    • No intervention
    • Tucson, Arizona
    • +85 more
    Dec 20, 2022

    Healthy Trial in Austin (ARRY-371797, p38 inhibitor; oral, Placebo; oral)

    Completed
    • Healthy
    • ARRY-371797, p38 inhibitor; oral
    • Placebo; oral
    • Austin, Texas
      PPD Phase I Clinic
    Sep 17, 2020

    Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • B-Cell Lymphoproliferative Disorder
    • Boston, Massachusetts
    • +2 more
    Feb 18, 2023

    Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

    Not yet recruiting
    • Alzheimer Disease
    • Placebo
    • +2 more
    • Paris, France
      Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
    Sep 29, 2022

    Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
      • Rotterdam, Netherlands
        Erasmus MC
      Feb 2, 2022

      Cushing Disease Trial (Fimepinostat)

      Not yet recruiting
      • Cushing Disease
      • (no location specified)
      Jul 31, 2023